Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Non-Current Debt (2020 - 2025)

Definitive Healthcare's Non-Current Debt history spans 6 years, with the latest figure at $156.1 million for Q4 2025.

  • For Q4 2025, Non-Current Debt fell 31.95% year-over-year to $156.1 million; the TTM value through Dec 2025 reached $156.1 million, down 31.95%, while the annual FY2025 figure was $156.1 million, 31.95% down from the prior year.
  • Non-Current Debt reached $156.1 million in Q4 2025 per DH's latest filing, down from $158.2 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $265.4 million in Q3 2021 to a low of $156.1 million in Q4 2025.
  • Average Non-Current Debt over 5 years is $229.5 million, with a median of $244.2 million recorded in 2023.
  • Peak YoY movement for Non-Current Debt: crashed 42.3% in 2021, then decreased 2.38% in 2022.
  • A 5-year view of Non-Current Debt shows it stood at $263.8 million in 2021, then fell by 3.05% to $255.8 million in 2022, then dropped by 5.16% to $242.6 million in 2023, then dropped by 5.44% to $229.4 million in 2024, then tumbled by 31.95% to $156.1 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Non-Current Debt are $156.1 million (Q4 2025), $158.2 million (Q3 2025), and $160.3 million (Q2 2025).